Argenx US, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$13Mgeneral payments (2019-2025)
$137Kresearch payments (2019-2025)
10,929clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2022 $2.4M
2023 $3.2M
2024 $3.4M
2025 $4.4M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $6.4M
Neuromuscular Medicine (Psychiatry & Neurology) $1.6M
Hematology & Oncology $643K
Rheumatology $360K
Clinical Neurophysiology $328K
Dermatology $230K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Pamela Klein Los Angeles, CA $1,800,882.31
Pamela Klein San Francisco, CA Hematology & Oncology $509,601.13
Jeffery Allen Minneapolis, MN Neurology (Psychiatry & Neurology) $269,994.76
Kenneth Gorson Wellesley, MA Neurology (Psychiatry & Neurology) $266,190.60
Tuan Vu Tampa, FL Neurology (Psychiatry & Neurology) $236,681.07
Samir Macwan Rancho Mirage, CA Neuromuscular Medicine (Psychiatry & Neurology) $218,517.45
Barry Vaught Crab Orchard, WV Neurology (Psychiatry & Neurology) $208,337.88
Nicholas Silvestri Buffalo, NY Neuromuscular Medicine (Psychiatry & Neurology) $200,914.87
Raghav Govindarajan O Fallon, IL Neuromuscular Medicine (Psychiatry & Neurology) $198,509.27
Suraj Muley Phoenix, AZ Neurology (Psychiatry & Neurology) $189,767.56

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.